Chapter 10. Second Trimester Biochemical Screening for Neural Tube Defects and Aneuploidy
- John T. Queenan MD Professor Chairman Emeritus1,
- John C. Hobbins MD Professor of Obstetrics2,
- Catherine Y. Spong MD Chief3
Published Online: 30 APR 2009
DOI: 10.1002/9781444312904.ch10
Copyright © 2005 Blackwell Publishing Ltd
Book Title
Protocols for High-Risk Pregnancies, Fourth Edition
Additional Information
How to Cite
Hobbins, J. C. (2009) Second Trimester Biochemical Screening for Neural Tube Defects and Aneuploidy, in Protocols for High-Risk Pregnancies, Fourth Edition (eds J. T. Queenan, J. C. Hobbins and C. Y. Spong), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444312904.ch10
Editor Information
- 1
Department of Obstetrics and Gynecology, Georgetown University School of Medicine, 3257 N Street NW, Washington, DC 20007, USA
- 2
University of Colorado Health Sciences Center, Department of Obstetrics and Gynecology, 4200 East 9th Avenue, B-198, Denver, CO 80262, USA
- 3
National Institute of Child Health and Human Development, Center for Developmental Biology and Perinatal Medicine, Pregnancy and Perinatology Branch, National Institutes of Health, 6100 Executive Bivd, Bethesda, MD 20892-7510, USA
Publication History
- Published Online: 30 APR 2009
- Published Print: 9 SEP 2005
ISBN Information
Print ISBN: 9781405125796
Online ISBN: 9781444312904
- Summary
- Chapter
Keywords:
- biochemical screening (BCS);
- neural tube defects (NTDs);
- maternal serum alpha-fetoprotein (MSAFP);
- human chorionic gonadotropin (hCG);
- age-related risk (ARR);
- second trimester biochemical screening for neural tube defects and aneuploidy
Summary
This chapter contains sections titled:
Introduction
Screening for Neural Tube Defects
The Spine
Other Areas to Explore
Screening for down Syndrome
Contemporary Interpretation and Diagnostic Management of Biochemical Screening
Risk of Amniocentesis
Genetic Sonogram
Screening for Trisomy 18
Biochemical Screening and Adverse Pregnancy Outcome
Suggested Reading